Irinotecan hydrochloride trihydrate
Product #:
TL0473
Image
SKU-Pack Size
Stock
Price($)
Quantity
-
-
TL0473-25MG
In stock
36.8
-
+
TL0473-100MG
In stock
68.6
-
+
TL0473-250MG
In stock
137
-
+
TL0473-1G
In stock
363.4
-
+
Details
l General Information |
Product Name | Irinotecan hydrochloride trihydrate |
General description | Irinotecan, a prodrug, is converted to a biologically active metabolite SN-38 by a carboxylesterase converting enzyme. |
Synonym | Irinotecan monohydrochloride trihydrate; Irinotecan HCl Trihydrate; CPT-11 |
Purity | ≥99.0%(HPLC) | CAS Number | 136572-09-3 |
Formula | C33H45ClN4O9 | Molecular Weight | 677.18 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Pale yellow to yellow solid |
Solubility(25℃) | DMSO | ≥50mg/mL |
Ethanol | Slightly soluble |
Water | Slightly soluble |
l Biological Information |
Biochem/Physiol Actions | Irinotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent. |
Application | 1. Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. 2. Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. 3. Topoisomerase I Inhibitors Compounds that inhibit the activity of DNA Topoisomerase I. |
l Packaging & Storage |
Packaging | 25mg; 100mg; 250mg; 1g |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |